Molecularly Imprinted Polymers (MIPs) as Theranostic Systems for Sunitinib Controlled Release and Self-Monitoring in Cancer Therapy

• Autors principals: Ortensia Ilaria Parisi (Autor), Mariarosa Ruffo (Autor), Rocco Malivindi (Autor), Anna Francesca Vattimo (Autor), Vincenzo Pezzi (Autor), Francesco Puoci (Autor)
• Format: Llibre
• Publicat: MDPI AG, 2020-01-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Cytotoxic agents that are used conventionally in cancer therapy present limitations that affect their efficacy and safety profile, leading to serious adverse effects. In the aim to overcome these drawbacks, different approaches have been investigated and, among them, theranostics is attracting inter...